 |
PDBsum entry 5e2k
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
4-Arylbenzenesulfonamides as human carbonic anhydrase inhibitors (hcais): synthesis by pd nanocatalyst-Mediated suzuki-Miyaura reaction, Enzyme inhibition, And X-Ray crystallographic studies.
|
 |
|
Authors
|
 |
B.Cornelio,
M.Laronze-Cochard,
M.Ceruso,
M.Ferraroni,
G.A.Rance,
F.Carta,
A.N.Khlobystov,
A.Fontana,
C.T.Supuran,
J.Sapi.
|
 |
|
Ref.
|
 |
J Med Chem, 2016,
59,
721-732.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Benzenesulfonamides bearing various substituted (hetero)aryl rings in the
para-position were prepared by palladium nanoparticle-catalyzed Suzuki-Miyaura
cross-coupling reactions and evaluated as human carbonic anhydrase (hCA, EC
4.2.1.1) inhibitors against isoforms hCA I, II, IX, and XII. Most of the
prepared sulfonamides showed low inhibition against hCA I isoform, whereas the
other cytosolic isoenzyme, hCA II, was strongly affected. The major part of
these new derivatives acted as potent inhibitors of the tumor-associated isoform
hCA XII. An opposite trend was observed for phenyl, naphthyl, and various
heteroaryl substituted benzenesulfonamides which displayed subnanomolar hCA IX
inhibition while poorly inhibiting the other tumor-associated isoform hCA XII.
The inhibition potency and influence of the partially restricted aryl-aryl bond
rotation on the activity/selectivity were rationalized by means of X-ray
crystallography of the adducts of hCA II with several 4-arylbenzenesulfonamides.
|
 |
|
|
|
|
 |